Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Iovance Biotherapeutics, Inc. Common Stock | IOVA

Daily Technical Analysis of Iovance Biotherapeutics, Inc. Common Stock

Iovance Biotherapeutics had a nice pop today and is currently up 5.11% -- which is pretty good. Investors have a more positive outlook for the company and future revenue.

It looks like Iovance Biotherapeutics isn't currently at a very decisive point in regards to support/resistance levels. Iovance Biotherapeutics has looked pretty good over the last few months. It has definitely cuaght a bid and had a nice run. Over the last 3 months, shareholders are no doubt pleased to see a 87.59 percent return. IOVA might find some support at the 9.85 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for Iovance Biotherapeutics By Price Target And Rating

The analysts feel pretty optimistic about Iovance Biotherapeutics and have been assigning positive ratings. The current Analysts Sentiment Score is 208.87. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Wells Fargo & Company boosted their price targ by 13.64% to $25.00 on 2024-03-01. On 2024-02-29 Barclays increased their price target by 22.22% to $22.00. On 2024-02-29 HC Wainwright reiterated their rating of Buy and added a price target of $32.00. On 2024-02-29 The Goldman Sachs Group increased their price target by 10.53% to $21.00. JMP Securities gave a boost to their price target and moved to $25.00 from $18.00 on 2024-02-20. Piper Sandler gave a boost to their price target and moved to $18.00 from $14.00 on 2024-02-20. Chardan Capital decided to move up their price target on 2024-02-20 to $34.00 which is a 17.24% increase. On 2023-12-27 there was confirmation of the previous rating by Truist Financial which was Buy and added a price target of $17.00. Mizuho reiterated a rating of Buy on 2023-09-15 and added a price target of $30.00. On 2023-09-13 Stifel Nicolaus lowered their price target by -3.7% to $26.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
IOVA208.87120.210300.34-2.8

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-03-12)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
IOVA0.000.00

Short interest for Iovance Biotherapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
IOVA15.01%19.46.420.65838740000

How Iovance Biotherapeutics compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
1060.402.02-4.9513.5139.3530.6437.8634.1814.9613.67-13850.04-11280.963.3023.589.5573.63
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
2490.712.38-0.949.1925.0619.3941.7731.7711.2311.41-12872.42-11623.084.9217.176.9353.26

Social Sentiment for Iovance Biotherapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
IOVA

Companies with the highest correlation to Iovance Biotherapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
EDIT | Editas Medicine, Inc. Com1.26-0.27-0.67-29.53-21.657.230.13261.11-0.78-6.75-18653.05-1877.60010016.4101
SDGR | Schrodinger, Inc. Common 1.151.390.860.71-16.69-1.399.6241-9.59-8.05-8.61-7848.89-3412.90009.02067
CRSP | CRISPR Therapeutics AG1.14-2.85-4.82-18.618.9544.6255.441257.6450.1337.40-2101.92-9760.98015015.3247
TDOC | Teladoc Health, Inc.1.12-1.110.670.67-28.91-18.51-39.6743-24.98-33.71-40.36-27887.95-843.48008.78425
BEAM | Beam Therapeutics Inc. Co1.08-2.71-1.75-17.0727.9637.556.513727.5627.4518.28-12310.25-3714.820018.782
EXAS | Exact Sciences Corp1.063.2611.2116.18-1.26-0.142.9146-36.35-38.66-24.05-14136.19-7085.87005.2321

Top 3 correlating companies

See full charts for all peers

Sentiment Score

Last updated 2022-02-01 16:11:14

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-